Toyota says it has made a technological breakthrough that will allow it to halve the weight, size and cost of batteries, in what could herald a major advance for electric vehicles. The world’s second largest carmaker was already pursuing a plan to roll out cars with advanced solid-state batteries, which offer benefits compared with liquid-based
Read More …
This chart from Chris Hamilton at Econimica grabbed our attention, not as an immediate indicator, but rather, as a jaw-dropping piece of context. An attempt to see the forest for the trees, if you will. 1980: Everybody hates the [US Dollar (USD)] and [US Treasury Bonds (USTs)], even as US Federal debt is 40% collateralized
Read More …
The gold market could see new bullish momentum as the world could see a new type of gold standard. Friday, according to state-run RT, the Russian government has confirmed that Brazil, Russia, India, China and South Africa, also known as BRICS nations, will introduce a new trading currency backed by gold. The official announcement is
Read More …
Changes to solar panel technology are accelerating demand for silver, a phenomenon that’s widening a supply deficit for the metal with little additional mine production on the horizon. Silver, in paste form, provides a conductive layer on the front and the back of silicon solar cells. But the industry is now beginning to make more
Read More …
Elliott Investment Management has built a significant stake in Catalent (CTLT) and is pushing for a shake-up on the contract drugmaker’s board. Elliott has been talking to potential director candidates about joining a slate of nominees to run in a proxy contest, people familiar with the matter said. The exact size of Elliott’s stake couldn’t
Read More …
Elliott loaded up on the offshore name through equity swaps; looks like they are now at 15.65% of Seadrill’s share capital. The boilerplate 13D filing doesn’t really tell what their intentions are. Curiously following this as it involves one of our favorite themes. This is the second week Elliott popped up with reporting positions in
Read More …
Knight Therapeutics Inc. (TSX:GUD) (“Knight” or the “Company “), a leading pan-American (ex-US) specialty pharmaceutical company, announced today acceptance by the Toronto Stock Exchange (the “TSX”) of the Company’s Notice of Intention to Make a Normal Course Issuer Bid (“NCIB”). Pursuant to the NCIB, the Company proposes to purchase, from time to time over the
Read More …
